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Ectodermal dysplasias (ED) are uncommon genetic disorders resulting in abnormalities
in ectodermally derived structures. Many ED-associated genes have been described, of
which ectodysplasin-A (EDA) is one of the more common. The NF-κB essential modulator
(NEMO encoded by the IKBKG gene) is unique in that mutations result in severe humoral
and cellular immunologic defects in addition to ED. We describe three unrelated kindreds
with defects in both EDA and IKBKG resulting from X-chromosome crossover.This demon-
strates the importance of thorough immunologic consideration of patients with ED even
when an EDA etiology is conﬁrmed, and raises the possibility of a speciﬁc phenotype
arising from coincident mutations in EDA and IKBKG.
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INTRODUCTION
Ectodermal dysplasias (ED) comprise over 150 heterogeneous
phenotypes in which the formation of structures arising from the
ectodermal cell layer is impaired to some degree. Several causative
gene pathways have been identiﬁed, including proteins involved in
gap junctions, cell adhesion, ectoderm-speciﬁc transcription fac-
tors, andmembers of theTNF/TNFr superfamily (Itin andFistarol,
2004). Importantly, while infections have been reported to occur
at increased incidence in ED (Clarke et al., 1987), most forms do
not impact the immune system.
Several of the better-deﬁned causes of ED result from muta-
tions in the ectodysplasin-A (EDA) signaling pathway. EDA is a
membrane-bound signaling molecule of the TNF superfamily and
via interaction with its EDA-receptor (EDAR, a TNF superfamily
receptor) plays a role in signaling between ectodermal and meso-
dermal cell layers during embryogenesis (Mikkola and Thesleff,
2003). Defects in this pathway result in hypohidrotic ectodermal
dysplasia (HED), characterized by absent sweat glands, hypodon-
tia/oligodontia, hypotrichosis, eczema, and distinctive facial fea-
tures including frontal bossing and a depressed nasal bridge.
Approximately 80% of cases of HED are caused by mutations
in the gene EDA (OMIM 305100, XLHED, ectodermal dysplasia,
type 1; ED1) on the X-chromosome, while a smaller subset of
cases is caused by mutations in the EDAR, the adapter protein
EDARADD, or WNT10A (Chassaing et al., 2010; Cluzeau et al.,
2011). Defects in these latter genes can manifest with autosomal
recessive (ectodermal dysplasia anhidrotic; EDA; OMIM 224900)
and autosomal dominant forms (ectodermal dysplasia type 3;ED3;
OMIM 129490).
Although EDA pathway defects have no discernable affect on
the immune system, hypomorphic mutations in the NF-κB essen-
tial modulator (NEMO) encoded by the X-linked IKBKG gene,
result in HED with immunodeﬁciency (HED-ID or EDAXID,
OMIM 300291). NEMO is an integral component of the inhibitor
of NF-κB (IκB)-kinase (IKK) complex, which affects the phos-
phorylation of IκB, and thereby allows nuclear translocation of
NF-κB (Dofﬁnger et al., 2001; Orange et al., 2005). HED-ID is
characterized by exquisite susceptibility to mycobacteria, pyogenic
bacteria, and herpesviruses due to the essential role played by
NF-κB signaling in both innate and adaptive immunity (Orange
et al., 2005; Hanson et al., 2008). The immunologic phenotype
of HED-ID is therefore diverse and highly mutation dependent,
having the potential to impact Toll-like receptor (TLR) function,
immunoglobulin class switch recombination, and T-cell function.
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Of note,NF-κB is an essential downstreamcomponent of the EDA,
RANK-ligand, and VEGFR-3 pathways, and accordingly, observed
phenotypes in HED-ID variably include ectodermal dysplasia,
osteoclast abnormalities, and lymphedema (Orange et al., 2005;
Hanson et al., 2008), as mutations of these individual genes result
in these speciﬁc isolated phenotypes (Kere et al., 1996; Hughes
et al., 2000; Karkainnen et al., 2000). Heterozygous null mutations
or large deletions of IKBKG in females are associated with the
rare neurocutaneous disorder incontinentia pigmenti (IP). Unlike
the hypomorphic mutations associated with HED-ID, these larger
defects are lethal to male offspring in utero (Dupuis-Girod et al.,
2002; Fusco et al., 2008).
EDA is located on Xq12-q13, and the prevalence of HED is
estimated to affect 1 in 100,000 newborns (Clarke, 1987). IKBKG
is located on Xq28, and HED-ID occurs in approximately 1
in 250,000 newborns (Orange et al., 2004). Here, we describe
three unrelated patients with HED-ID, who were found to have
mutations in both EDA and IKBKG thus raising true diagnostic
challenges when considering the etiology of HED.
MATERIALS AND METHODS
PATIENT DATA
Clinical information was obtained via chart review after IRB
approval from the host institutions.
GENE SEQUENCE ANALYSIS
Genomic DNA and cDNA were prepared from patient leukocytes.
Bi-directional DNA gene sequencing of all EDA and IKBKG exons
was performed with genomic DNA from the patients as previously
described (Orange et al., 2004), and targeted gene sequencing was
subsequently performed to assess mutation status in relatives. Ref-
erence sequences used for this work were: EDA (NM_001399) and
IKBKG (NM_001099856).
IMMUNOLOGIC ASSAYS
Serum immunoglobulin concentrations (determined by neph-
elometry), antibody titers, and leukocyte enumeration were mea-
sured in the Children’s Hospital Clinical, or other CLIA-certiﬁed
Laboratories and were compared with laboratory speciﬁc, age-
related normal values.
RESULTS
CASE 1
The proband was a 2-year-old male with failure to thrive and
recurrent infections (Table 1). He developed feeding intolerance,
diarrhea, and failure to thrive in the ﬁrst months of life, which was
considered tobe a result of food allergy. This didnot improve,how-
ever, in response to a strict elemental diet. Beginning at 5months
of life, he experienced recurrent infections, including lymphadeni-
tis and bacteremia with Staphylococcus, Streptococcus species, and
Haemophilus inﬂuenzae. He also developed 5weeks of persistent
rash after receiving the live Varicella virus vaccine that required
treatment with varicella immunoglobulin.
The family history was notable for a maternal uncle (Figure 1A,
I5) who died at 8months of age due to lymphangiectasia and
dehydration. There was also a maternal ﬁrst cousin who had gran-
ulomatous colitis, ectodermal abnormalities and died at 3 years
of age because of E. coli bacteremia (I7). Several other maternal
relatives had milder ﬁndings suggestive of ectodermal dysplasia,
which mainly comprised of dental abnormalities (missing teeth,
enamel defects).
The proband’s physical ﬁndings included sparse hair, hypodon-
tia with conical teeth, and edema of the lower extremities and
scrotum (Figure 2). Radiologic studies were suggestive of osteope-
nia (Figure 3), and a lumbar spine dual X-ray absorptiometry
scan showed low normal bone mass for age (Z -score=−1.0).
Immunologic evaluation identiﬁed normal numbers of T-cells,
B-cells, and NK cells (Table 2), as well as lymphocyte prolifera-
tion in response to mitogens phytohemagglutinin, concanavalin
A, and pokeweed that were comparable to control donors. Quan-
titative immunoglobulin levels deﬁned hypogammaglobulinemia
and elevated IgM, along with vaccine-antigen speciﬁc IgG titers
(tetanus, diphtheria, H. inﬂuenzae, Streptococcus pneumoniae, and
two of three polio strains) that were below protective ranges
despite his having received these vaccines. Analysis of B-cell sub-
sets demonstrated naïve B-cells, and decreased switched memory
B-cells (Table 2). TLR induced-TNF production (especially TLR7
and TLR9) and TNF-induced IκB degradation were impaired (not
shown).
Due to the presence of ED, the patient’s EDA gene was
sequenced. A c.458G>A substitution in exon 3 was identiﬁed,
predicting an arginine to histidine missense mutation at amino
acid position 153 (p.R153H). No similar mutation was found in
several publically available databases of single nucleotide polymor-
phisms (data not shown). This region was previously described to
correspond to the furin domain of EDA and thus the mutation
was predicted to be impactful (Schneider et al., 2001). Sequence
analysis of the IKBKG gene was performed as well due to evi-
dence for immunodeﬁciency and identiﬁed a nucleotide substi-
tution (c.518+5G>A or IVS6+5G>A), previously described to
result in abnormal splicing with generation of a NEMO pro-
tein excluding the region corresponding to three exons (Orstavik
et al., 2006). This mutation was also associated with the clinical
syndrome of HED-ID. Analysis of NEMO protein expression in
the proband’s PBMC by western blot conﬁrmed abnormally sized
Table 1 | Clinical characteristics of patients.
Patient Bacterial infections Viral infections Clinical features Current status
1 Lymphadenitis/bacteremia: Staphylococcus,
Streptococcus, H. inﬂuenza; C. Difﬁcile colitis
Parainﬂuenza, VZV
(vaccine strain)
Hypodontia, hypotrichosis, hypohidrosis,
lymphedema, osteoporosis
Died, age 5, post-bone
marrow transplant
2 Sinusitis None Hypodontia, hypotrichosis, eczema Alive
3 Sinusitis, otitis media, pneumonia None Hypodontia, hypotrichosis, hyphidrosis Alive
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FIGURE 1 | Family trees demonstrate the inheritance of EDA (red)
and IKBKG (blue) mutations. (A) In the family of patient #1, a male
maternal cousin of patient #1 (I7) had died with a diagnosis of
granulomatous colitis. Multiple members also demonstrated dental
abnormalities (D). (B) In the family of patient #2, the brother (I5) had features
of ectodermal dysplasia (ED). No family history was available for family 3. (C)
The respective positions of EDA and IKBKG on the long arm of the
X-chromosome are depicted.
FIGURE 2 | Lower extremity edema in patient #1.
protein consistent with the published report of this mutation (not
shown; Orstavik et al., 2006).
DNA from the proband’s family members were subsequently
analyzed for sequence of their EDA and IKBKG genes (Figure 1A).
This demonstrated the presence of the mutant EDA and IKBKG
genes in the maternal grandfather (I1) and grandmother (I2),
respectively. Two of the daughters (I3, I6) inherited both of the
mutant genes. One of these was the proband’s mother (I6), while
the other daughter (I3) had a child with ectodermal dysplasia (I7)
whodied frombacteremia at 3 years of age.Whilematerial for gene
sequencing was not available from the deceased cousin, a recombi-
nation event must have occurred in the proband’s mother. While
it was not clear if the presence of the two mutant genes resulted in
an exacerbated phenotype in the proband, examination of the two
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FIGURE 3 | Radiographs of patient #1 demonstrated osteopenia,
multiple growth recovery lines, and diminished tubulation of long
bones. DEXA showed lumbar spine L1–4 bone mineral density of
0.412 g/cm2, Z -score=−1.0.
males possessing only the EDA mutation (I8, I9) was performed.
While both had mild dental abnormalities, neither had ﬂorid HED
or history suggestive of immunodeﬁciency. Finally, the proband’s
sister (I10), who is unaffected, was found to carry the mutation in
IKBKG, but no mutation in EDA. Thus, in this ﬁrst family, while
the EDA mutation was likely to have at least some affect, the most
clinically relevant inheritance was of the IKBKG mutation. Given
the family members available for sequence analysis it is not possi-
ble to conclude if the proband had a more severe presentation due
to the inheritance of the two mutant genes.
After he was diagnosed with HED-ID the patient was treated
with intravenous immunoglobulin and prophylactic antibiotics.
After his health improved,at age 3.5 years of age hewas treatedwith
a matched-unrelated bone marrow transplantation. The details
of this are reported elsewhere (Fish et al., 2009), but it was
unsuccessful and he died from Parainﬂuenza infection following
engraftment failure.
CASE 2
The proband was diagnosed with HED as an 8-year-old male.
He had a history of severe generalized eczema and ectodermal
dysplasia as characterized by severe hypodontia, dystrophic nails
and hypotrichosis. He had a relatively benign history of infections
including only sinusitis. There was a history of dental abnormal-
ities in both the proband’s mother (Figure 1B, I1), 15-year-old
sister (I2), and 5-year-old brother (I3), who also had sparse hair
and eczema. There was no history in the family of recurrent
infections or premature deaths, and the proband’s siblings and
maternal uncles were healthy.
Due to his history of sinusitis and eczema, immunologic studies
of the proband were performed and demonstrated normal quan-
titative immunoglobulins, elevated IgE, and protective antibody
responses to his previous tetanus and H. inﬂuenzae vaccina-
tions. Titers to S. pneumoniae serotypes were initially poor, but
boosted appropriately following re-vaccination. Lymphocyte sub-
sets were within normal ranges as were proliferative responses to
phytohemagglutinin and pokeweed (Table 2).
Due to the presence of ectodermal dysplasia, the EDA gene was
sequenced in the proband and analysis demonstrated a hemizy-
gous c.1045G>A substitution, resulting in a predicted p.A349T
missense mutation. This mutation has been previously described
(Schneider et al., 2001), and corresponds to the TNF homology
domain. Sequencing of the IKBKG gene was also performed due
to history of sinusitis, and identiﬁed a hemizygous c.337G>A
nucleotide substitution, resulting in a predicted p.D113Nmissense
mutation, which has been previously described to be associated
with immunodeﬁciency without causing HED (Salt et al., 2008).
Heterozygous mutations in both EDA and IKBKG were found in
hismother and eldest sister,while his brotherwas found to have the
hemizygous EDA mutation only (Figure 1B). While the distinct
origins of these two mutations was not identiﬁed as in the ﬁrst
case, the proband’s brother had only the EDA mutation suggest-
ing a recombination event unique to the proband. The proband’s
mild history of infection has continued and his immune status
continues to be monitored.
CASE 3
The proband was an adopted male with hypotrichosis, hypohidro-
sis, and hypodontia born to a mother of Italian descent. He had a
history of recurrent sinusitis, otitis media, and an episode of lobar
pneumonia requiring hospitalization at age 11months. Due to his
history of infections, immunologic laboratory studies were per-
formed when he was 3.5 years old, which identiﬁed decreased IgG,
and IgA compared to normal values for the patient’s age (Table 2).
Analysis of lymphocyte subsets identiﬁed decreased CD4 Mem-
ory T-cells (absolute CD3+/CD4+/CD45RO: 169 cells/μL, nor-
mal: 203–975) and decreased CD8 Memory T-cells (absolute
CD3+/CD8+/CD45RO: 37 cells/μL, normal: 34–309). Pneumo-
coccal titers were non-protective (<1.3μg) for 10/14 serotypes
checked randomly at 3.5 years.
Because of the presence of ectodermal dysplasia, initially EDA
was sequenced, and demonstrated a hemizygous c.466C>T sub-
stitution predicting a p.R156C missense mutation, which has
been previously described in ED (Schneider et al., 2001). Due
to the proband’s history of infections and immune abnormal-
ities, his IKBKG gene was also sequenced and analysis identi-
ﬁed a c.169G>A substitution, predicted to cause a p.E57K mis-
sense mutation. This mutation has been previously reported
in association with IP (Fusco et al., 2004; Gautheron et al.,
2010). Due to the proband having been adopted, additional
biological family members were not available for sequence
analyses.
The proband was treated with immunoglobulin replacement
and prophylactic azithromycin against mycobacterial infections.
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Hehasdevelopednormally andhasnot experienced any signiﬁcant
infectious episodes.
DISCUSSION
Wedescribe three patientswithmutations in bothEDA and IKBKG
genes who have had features that could be attributed to one or the
other gene abnormalities. In each of the three families there were
additional family members with related features suggesting the
inﬂuence of the individual gene mutations. This series empha-
sizes the importance of ascertaining the complete historical and
family details and speciﬁcally considering distinct features that
might suggest gene mutations with overlapping clinical impact.
In this case both EDA and IKBKG gene mutations could be con-
ceived to contribute to the clinical presentations of the patients.
EDA mutation, however, should not account for the immunologic
and infectious features presented here. Importantly, in X-linked
disorders the possibility for males affected by a second clinically
overlapping disorder resulting from a distinct alteration of the
X-chromosome should be considered.
The immunologic and ED phenotypes in HED-ID are highly
mutation dependent, and the associations of speciﬁc muta-
tions with particular phenotypes have been reported previously
(Cluzeau et al., 2011). In particular there are speciﬁc IKBKG muta-
tions that do not cause ED (Nihues et al., 2004; Orange et al., 2004;
Hanson et al., 2008). Presently this accounts for one-quarter of
patients diagnosed with a clinically impactful IKBKG mutation.
In general mothers carrying an IKBKG mutation do not demon-
strate features of ED, but rare mutations associated with an IP
phenotype have been observed (Dupuis-Girod et al., 2002; Fusco
et al., 2008). These are considered to be quite rare,however, asmost
IP-causing mutations of IKBKG in women are incompatible with
survival of males inheriting a single copy of themutant-containing
X-chromosome (Smahi et al., 2000).
In contrast to the presence or absence of ED, all males with
IKBKGmutation appear to possess at least somevariety of immun-
odeﬁciency. The immunodeﬁciency, however, is quite variable and
may result from defects in signaling through the T-cell receptor, B-
cell receptor, NK cell receptors, TLRs, CD40, as well as other TNF
superfamily receptors, all of which are upstream of NF-κB. Some
IKBKG mutations are more likely to affect particular immune
functions; for example, some typically cause hypogammaglobu-
linemia, while others (particularly impacting the NEMO leucine
zipper domain) often do not (Hanson et al., 2008). Some muta-
tions are associated with T-cell defects, though selective memory
defects have been mostly attributed to mutations in the down-
stream protein Inhibitor of kB (IKBα; Courtois et al., 2003).
Mature/memory T-cells have been shown to depend on signal-
ing through the IKK complex (Schmidt-Supprian et al., 2003),
which may explain the low memory T-cell phenotype observed in
these patients.
While conceivable, phenotypic heterogeneity attributable to
particular genemutations inEDA-relatedHEDhas not been found
(Monreal et al., 1998; Schneider et al., 2001; Vincent et al., 2001).
Thus it is unclear if and how the EDA variants identiﬁed in the
patients we describe affect their phenotype. In the second case, it
is quite likely that the EDA mutation has imparted the HED, since
this particular IKBKG mutation has been reported previously to
not cause HED. However, he did not seem to have a signiﬁcant
immunologic phenotype, with sinusitis being his only infectious
problem. It was previously reported that D113N mutations in
IKBKG may impart susceptibility to opportunistic infections with
Pneumocystis or herpesviruses, but the mutations does not seem
to impart susceptibility to encapsulated bacteria (Hanson et al.,
2008). The same mutation has further been deﬁned to cause a
T-cell functional defect (Salt et al., 2008), which was not speciﬁ-
cally evaluated in our patient. His minimal infectious history may
reﬂect heterogeneity in the immunologic phenotype of this muta-
tion, as few patients have been described. In the other two cases,
individual or combined contributions of the EDA and IKBKG
mutations are less clear. With the IKBKG mutation found in the
ﬁrst case, severe immunodeﬁciency and HED have been previ-
ously reported (Orstavik et al., 2006). The mild appearance of
ED-related ﬁndings in family members who possessed only the
EDA mutation (Family 1) suggests it was of minimal impact. The
mutation described for EDA in this case had not previously been
reported and would be predicted to only result in a minor charge
variation via a single amino acid change. It is unclear, however, if
inheritance of both mutations on a single chromosome resulted
in an exacerbated clinical phenotype in the proband. Sequence
analysis of the deceased cousin or uncle might have provided some
clarity, but these samples were not available. It is worth consider-
ing,however, if this particular occurrencemight have impacted the
negative outcome of the hematopoietic stem cell transplantation
via graft failure because of some unusual effect on the bone mar-
row stromal/physical environment. With regards to the third case,
the EDA mutation was classic for being associated with disease,
and the IKBKG mutation was associated with IP, but not HED-
ID (Fusco et al., 2004; Gautheron et al., 2010). The presence of
immunodeﬁciency, however, implies the impact of the latter while
its contribution to ED or the inﬂuence of the combined mutations
is unclear for the patient. Thus in all three of the probands, it
is difﬁcult to attribute all of the clinical impact to one of the two
mutant genes, and it would appear likely that some affect is derived
from both. What remains unclear is if combined EDA and IKBKG
mutations are more severe than IKBKG alone. The ﬁrst case sug-
gests this might be valid, but cannot be proven at present. It does,
however, suggest the possibility for a speciﬁc disease phenotype
resulting from the coincidence of mutations. Given the experience
regarding Patient 1, it may be feasible to evaluate for this genotype
in considering hematopoietic stem cell transplantation.
While we report three unrelated cases, the concurrence of these
mutations is not expected to be common. The prevalence of
EDA-related HED is estimated to occur in less than 1 in 100,000
newborns (Clarke, 1987) and IKBKG-related HED-ID has also
been estimated to occur in approximately 1 in 250,000 newborns
(Orange et al., 2004). Thus the estimated chance of their occur-
rence in the same patient would be 1 in 25 billion. Were this to
be the case, however, we would effectively be reporting all of the
existing individuals with this particular genotype.
Due to the theoretical rarity of the diagnoses, one might con-
sider the possibility that the genetic events, i.e., mutations of both
EDA and IKBKG are linked.Although they are both genes on theX-
chromosome, further assessment suggests that the co-occurrence
exists by chance. This estimate is based upon data demonstrating a
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1.19-cM recombination frequency per megabase of the human X-
chromosome (Kong PMID: 12053178, Coop PMID: 18239090).
EDA is located at Xq13.1 at a genomic position ∼69Mb and
IKBKG is on Xq28at∼153Mb, a separation of 84Mb (Figure 1C).
This would predict a 70% chance of recombination, well above
50% indicative of random segregation. Thus, while not linked
per se, the coincidence is somewhat more likely than would be
predicted for distant loci. Therefore, there are likely to be other
patients possessing both EDA and IKBKG mutations in need of
more deﬁnitive molecular diagnosis.
This work emphasizes that the presence of a mutation in
EDA does not necessarily exclude the presence of a more seri-
ous defect in IKBKG. Early diagnosis may allow prevention
of life-threatening infections via prophylactic antibiotics and
immunoglobulin replacement. Thoughmost causes of ectodermal
dysplasia are not associated with immune defects, a high index of
suspicion iswarrantedwithHEDfor thepossibility of mutations in
IKBKG resulting in HED-ID. A thorough family history should be
performed in pursuit of clues suggesting immunodeﬁciency, espe-
cially in maternally related males. Immunologic screening should
be considered for all children with HED, and a thorough workup
is essential if there is any abnormal pattern of infections.
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